As of Sep 22
| +0.03 / +0.05%|
The 19 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 60.00, with a high estimate of 72.00 and a low estimate of 49.00. The median estimate represents a -5.30% decrease from the last price of 63.36.
The current consensus among 23 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.